We are live on ! Find out more

902 hedge funds and large institutions have $30.2B invested in Humana in 2025 Q1 according to their latest regulatory filings, with 140 funds opening new positions, 322 increasing their positions, 314 reducing their positions, and 105 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more call options, than puts

Call options by funds: $2.39B | Put options by funds: $1.62B

42% more funds holding in top 10

Funds holding in top 10: 1217 (+5)

33% more first-time investments, than exits

New positions opened: 140 | Existing positions closed: 105

3% more funds holding

Funds holding: 878902 (+24)

3% more repeat investments, than reductions

Existing positions increased: 322 | Existing positions reduced: 314

3% more capital invested

Capital invested by funds: $29.5B → $30.2B (+$740M)

1.84% less ownership

Funds ownership: 96.45%94.61% (-1.8%)

Holders
902
Holders Change
+24
Holders Change %
+2.73%
% of All Funds
12.07%
Holding in Top 10
17
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+41.67%
% of All Funds
0.23%
New
140
Increased
322
Reduced
314
Closed
105
Calls
$2.39B
Puts
$1.62B
Net Calls
+$771M
Net Calls Change
+$640M

HUM Hedge Fund Activity: Q1 2025 in Review

902 of the 7,471 institutional investors tracked by Wall St. Rank reported a position in Humana (HUM) for Q1 2025, worth a combined $30.2B — up 2.5% from $29.5B a quarter earlier.

Buyers outnumbered sellers: 140 funds opened new HUM positions and 105 closed out — a net gain of 35 holders — while 322 added to existing stakes and 314 trimmed.

The largest buyer was Vanguard Group, adding an estimated $309M. The largest seller was T. Rowe Price Associates, cutting an estimated $487M.

  • 902 institutional investors held Humana (HUM) as of Q1 2025, up from 878 in Q4 2024.
  • Funds reported $30.2B of Humana stock for Q1 2025, up 2.5% quarter-over-quarter.
  • 140 funds opened new Humana positions in Q1 2025 and 105 closed out, a net change of +35 holders.
  • The largest Humana buyer in Q1 2025 was Vanguard Group, an estimated $309M added.
  • The largest Humana seller in Q1 2025 was T. Rowe Price Associates, an estimated $487M sold.

Based on aggregated 13F filings for Q1 2025.